135 related articles for article (PubMed ID: 34521029)
1. Multifocal regression and pathologic response predicts recurrence after neoadjuvant chemotherapy in head and neck squamous cell carcinoma.
Kiong KL; Bell D; Yao CM; Ferrarotto R; Lewis CM
Oral Oncol; 2021 Nov; 122():105520. PubMed ID: 34521029
[TBL] [Abstract][Full Text] [Related]
2. Delay to surgery after neoadjuvant chemotherapy in head and neck squamous cell carcinoma affects oncologic outcomes.
Kiong KL; Yao CMKL; Lin FY; Bell D; Ferrarotto R; Weber RS; Lewis CM
Cancer; 2021 Jun; 127(12):1984-1992. PubMed ID: 33631040
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
4. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.
Ataseven B; Lederer B; Blohmer JU; Denkert C; Gerber B; Heil J; Kühn T; Kümmel S; Rezai M; Loibl S; von Minckwitz G
Ann Surg Oncol; 2015 Apr; 22(4):1118-27. PubMed ID: 25297900
[TBL] [Abstract][Full Text] [Related]
5. Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Ferrarotto R; Amit M; Nagarajan P; Rubin ML; Yuan Y; Bell D; El-Naggar AK; Johnson JM; Morrison WH; Rosenthal DI; Glisson BS; Johnson FM; Lu C; Mott FE; Esmaeli B; Diaz EM; Gidley PW; Goepfert RP; Lewis CM; Weber RS; Wargo JA; Basu S; Duan F; Yadav SS; Sharma P; Allison JP; Myers JN; Gross ND
Clin Cancer Res; 2021 Aug; 27(16):4557-4565. PubMed ID: 34187851
[TBL] [Abstract][Full Text] [Related]
6. Influence of pathologic complete response to neoadjuvant chemotherapy on long-term survival of patients with advanced head and neck squamous cell carcinoma.
Zhang XR; Liu ZM; Liu XK; Wang FH; Li Q; Li H; Li QL; Guo ZM; Zeng ZY
Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Feb; 115(2):218-23. PubMed ID: 23265986
[TBL] [Abstract][Full Text] [Related]
7. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
Haehl E; Rühle A; David H; Kalckreuth T; Sprave T; Stoian R; Becker C; Knopf A; Grosu AL; Nicolay NH
Radiat Oncol; 2020 Feb; 15(1):31. PubMed ID: 32019576
[TBL] [Abstract][Full Text] [Related]
9. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia dynamics on FMISO-PET in combination with PD-1/PD-L1 expression has an impact on the clinical outcome of patients with Head-and-neck Squamous Cell Carcinoma undergoing Chemoradiation.
Rühle A; Grosu AL; Wiedenmann N; Mix M; Stoian R; Niedermann G; Baltas D; Werner M; Weber WA; Kayser G; Nicolay NH
Theranostics; 2020; 10(20):9395-9406. PubMed ID: 32802199
[TBL] [Abstract][Full Text] [Related]
11. Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.
Rambeau A; Bastit V; Thureau S; Thariat J; Moldovan C; Roge M; Babin E; Gery B; Di Fiore F; Florescu C; Clatot F
Oral Oncol; 2019 Jun; 93():46-51. PubMed ID: 31109695
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemoimmunotherapy shows major pathological response and low recurrence in head and neck squamous cell carcinoma.
Yan S; Liu L; Zhang X; Wei L; Jiang W; Gao X; Yang A; Liu X; Chen W; Chen Y; Li H; Lin Q; Li M; Chen J; Zhang Q; Chen S; Song M
Clin Transl Oncol; 2024 May; 26(5):1192-1202. PubMed ID: 37989823
[TBL] [Abstract][Full Text] [Related]
13. Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.
Elbers JBW; Al-Mamgani A; van den Brekel MWM; Jóźwiak K; de Boer JP; Lohuis PJFM; Willems SM; Verheij M; Zuur CL
Otolaryngol Head Neck Surg; 2019 Jun; 160(6):1023-1033. PubMed ID: 30526317
[TBL] [Abstract][Full Text] [Related]
14. Survival and disease progression following solitary locoregional recurrence after head and neck radiotherapy.
Zhao L; Day AT; Moon D; Avkshtol V; Sumer BD; Hughes R; Sher DJ
Head Neck; 2022 May; 44(5):1153-1163. PubMed ID: 35212070
[TBL] [Abstract][Full Text] [Related]
15. Response to Neoadjuvant Targeted Therapy in Operable Head and Neck Cancer Confers Survival Benefit.
Mascarella MA; Olonisakin TF; Rumde P; Vendra V; Nance MA; Kim S; Kubik MW; Sridharan SS; Ferris RL; Fenton MJ; Clayburgh DR; Ohr JP; Joyce SC; Sen M; Herman JG; Grandis JR; Zandberg DP; Duvvuri U
Clin Cancer Res; 2023 Feb; 29(4):723-730. PubMed ID: 36595540
[TBL] [Abstract][Full Text] [Related]
16. Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.
Krstevska V
J BUON; 2015; 20(4):943-53. PubMed ID: 26416042
[TBL] [Abstract][Full Text] [Related]
17. Predictors of locoregional control in stage I/II oral squamous cell carcinoma classified by AJCC 8th edition.
Subramaniam N; Balasubramanian D; Murthy S; Kumar N; Vidhyadharan S; Vijayan SN; Nambiar A; Thankappan K; Iyer S
Eur J Surg Oncol; 2019 Nov; 45(11):2126-2130. PubMed ID: 31196702
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated Radiotherapy.
Ahmad P; Sana J; Slavik M; Gurin D; Radova L; Gablo NA; Kazda T; Smilek P; Horakova Z; Gal B; Hermanova M; Slampa P; Slaby O
Cancer Genomics Proteomics; 2019; 16(2):139-146. PubMed ID: 30850365
[TBL] [Abstract][Full Text] [Related]
19. Perineural Invasion As the Sole Pathologic Risk Factor After Surgical Resection for Head and Neck Squamous Cell Carcinoma.
Hughes RT; Farris J; Steber C; Frizzell BA; Greven KM
Cureus; 2021 Feb; 13(2):e13094. PubMed ID: 33692913
[TBL] [Abstract][Full Text] [Related]
20. Survival predictors and outcomes of patients with recurrent and/or metastatic head and neck cancer treated with chemotherapy plus cetuximab as first-line therapy: A real-world retrospective study.
Pontes F; Garcia AR; Domingues I; João Sousa M; Felix R; Amorim C; Salgueiro F; Mariano M; Teixeira M
Cancer Treat Res Commun; 2021; 27():100375. PubMed ID: 33882378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]